GreyBerry

GreyBerry | Joined since 2020-11-20

Investing Experience -
Risk Profile -

Followers

0

Following

0

Blog Posts

0

Threads

3

Blogs

Threads

Portfolio

Follower

Following

Summary
Total comments
3
Past 30 days
0
Past 7 days
0
Today
0

User Comments
Stock
Stock

2020-11-29 06:10 | Report Abuse

Someone said virus from wuhan.. then the best vaccine should be from wuhan.. right?

Stock

2020-11-20 21:19 | Report Abuse

mTouche’s latest announcement follows the one it made in April this year regarding the supply agreement its wholly-owned subsidiary, mTouche International Sdn Bhd, entered into with Network Global Solutions Pty Ltd to promote, market and distribute novel coronavirus (SAR-CoV-2) RT-PCR Detection and Diagnostic Kit by LabGenomics Co Ltd (South Korea) and novel coronavirus (SAR-CoV-2) IgM/IgG Rapid Test Kit by Qingdao Hightop Biotech Co Ltd (China), and other equivalent products in this region.

It was also appointed by Shanghai Fosun Long March Medical Science Co Ltd (China) and Wuhan EasyDiagnosis Biomedicine Co Ltd. (China) as the authorised representative to promote, market and distribute Covid-19 RT-PCR detection and diagnostic kits and Covid-19 IgM/IgG rapid test kits in Malaysia.

In its latest statement, mTouche said the test kits from LabGenomics, Shanghai Fosun and Wuhan EasyDiagnosis were the ones that have received approval.